Impact of donor NKG2D and MICA gene polymorphism on clinical outcomes of adult and paediatric allogeneic cord blood transplantation for malignant diseases
European Journal of Haematology · 2024
DOI: 10.1111/ejh.14202 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Steven T Cox und 12 weiteren Autor:innen. Beteiligte Einrichtung: Anthony Nolan Research Institute, Royal Free Hospital, London, UK. Hauptthemen laut MEDLINE: NK Cell Lectin-Like Receptor Subfamily K, Cord Blood Stem Cell Transplantation, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Anthony Nolan.
Abstract (Originalsprache)
Objectives
NKG2D is an activating receptor expressed by natural killer (NK) and CD8+ T cells and activation intensity varies by NKG2D expression level or nature of its ligand. An NKG2D gene polymorphism determines high (HNK1) or low (LNK1) expression. MICA is the most polymorphic NKG2D ligand and stronger effector cell activation associates with methionine rather than valine at residue 129. We investigated correlation between cord blood (CB) NKG2D and MICA genotypes and haematopoietic stem cell (HSC) transplant outcome.
Methods
We retrospectively studied 267 CB HSC recipients (178 adult and 87 paediatric) who underwent transplant for malignant disease between 2007 and 2018, analysing CB graft DNA for NKG2D and MICA polymorphisms using Sanger sequencing. Multivariate analysis was used to correlate these results with transplant outcomes.
Results
In adult patients, LNK1 homozygous CB significantly improved 60‐day neutrophil engraftment (hazard ratio (HR) 0.6; 95% confidence interval (CI) 0.4–0.9; p = .003). In paediatrics, HNK1 homozygous CB improved 60‐day engraftment (HR 0.4; 95% CI 0.2–0.7; p = .003), as did MICA‐129 methionine+ CB grafts (HR 1.7 95% CI 1.1–2.6; p = .02).
Conclusion
CB NKG2D and MICA genotypes potentially improve CB HSC engraftment. However, results contrast between adult and paediatric recipients and may reflect transplant procedure disparities between cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anthony Nolan Research Institute, Royal Free Hospital, London, UK.
- UCL Cancer Institute, Royal Free Campus, London, UK.
- Banc de Sang i Teixits, Barcelona, Spain.
- Eurocord, Hôpital Saint Louis APHP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris Cité, Paris, France.
- Department of Immunology and Inflammation, Imperial College London, London, UK.
- Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
ORCID-Profile: Steven T Cox, Sergi Querol, Francesc Rudilla Salvador, Diana Hernandez
Förderung
- Anthony Nolan
Zitieren
APA
Cox, S. T., Patterson, W., Duggleby, R., Jones, O. J. R., Madrigal, J. A., Querol, S., Salvador, F. R., Mata, M. J. H., Volt, F., Gluckman, É., Szydlo, R., Danby, R. D., & Hernandez, D. (2024). Impact of donor NKG2D and MICA gene polymorphism on clinical outcomes of adult and paediatric allogeneic cord blood transplantation for malignant diseases. European Journal of Haematology. https://doi.org/10.1111/ejh.14202
Vancouver
Cox ST, Patterson W, Duggleby R, Jones OJR, Madrigal JA, Querol S, et al. Impact of donor NKG2D and MICA gene polymorphism on clinical outcomes of adult and paediatric allogeneic cord blood transplantation for malignant diseases. European Journal of Haematology. 2024. doi:10.1111/ejh.14202
BibTeX
@article{Cox2024,
author = {Cox, Steven T and Patterson, Warren and Duggleby, Richard and Jones, Owen J R and Madrigal, J Alejandro and Querol, Sergi and Salvador, Francesc Rudilla and Mata, Maria Jose Herrero and Volt, Fernanda and Gluckman, Éliane and Szydlo, Richard and Danby, Robert D and Hernandez, Diana},
title = {Impact of donor NKG2D and MICA gene polymorphism on clinical outcomes of adult and paediatric allogeneic cord blood transplantation for malignant diseases},
journal = {European Journal of Haematology},
year = {2024},
doi = {10.1111/ejh.14202}
}
EUVIMED